Cancer-associated fibroblasts are a useful cytological finding for diagnosing pancreatic ductal adenocarcinoma

被引:4
|
作者
Saika, Tsubasa [1 ]
Hirabayashi, Kenichi [2 ]
Itoh, Hitoshi [1 ]
Miyajima, Yoko [1 ]
Serizawa, Akihiko [1 ]
Kato, Nobuaki [1 ]
Oyamada, Hiroyuki [3 ]
Machida, Tomohisa [4 ]
Kawanishi, Aya [5 ]
Nakamura, Naoya [2 ]
机构
[1] Tokai Univ Hosp, Div Diagnost Pathol, Isehara, Kanagawa, Japan
[2] Tokai Univ, Dept Pathol, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan
[3] Tokai Univ, Dept Clin Lab, Oiso Hosp, Oiso, Japan
[4] Tokai Univ, Dept Diagnost Pathol, Hachioji Hosp, Hachioji, Tokyo, Japan
[5] Tokai Univ, Dept Gastroenterol & Hepatol, Sch Med, Isehara, Kanagawa, Japan
关键词
JUICE; CARCINOMA; EXPERIENCE;
D O I
10.1111/cyt.12868
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction Cancer-associated fibroblasts (CAFs) are activated fibroblasts or myofibroblasts that play a crucial role in the invasiveness of pancreatic ductal adenocarcinoma (PDAC). In this study, the cytological features and diagnostic significance of CAFs based on pancreatic duct brushing cytology (PDBC) were evaluated. Methods The prevalence of fibrous stroma (FS) including CAFs on PDBC in 42 PDAC cases and 33 benign cases was retrospectively investigated. The average nuclear size of fibroblasts was compared between PDAC and benign cases to distinguish CAFs from normal FS. Results Overall, FS was observed in 25 PDAC cases (60%) and eight benign cases (24%). The average nuclear size of FS in PDAC cases was significantly larger than that in benign cases. From the receiver operating characteristics analysis, the cut-off value of the nuclear size of FS for the diagnosis of PDAC was defined as 10.22 mu m. FS with nuclei over 10.22 mu m in size in PDAC cases had clear prominent nucleoli. In contrast, FS in benign cases had no clear nucleoli. Thus, CAFs on PDBC were considered to be FS with nuclei over 10.22 mu m in size and prominent nucleoli. The presence of CAFs on PDBC had 100% positive predictive value and specificity for the diagnosis of PDAC. Conclusions This study suggested that CAFs on PDBC could be distinguished from normal FS by large nuclear size (over 10.22 mu m) and prominent nucleoli and that CAFs on PDBC may be used for the diagnosis of PDAC.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 50 条
  • [31] Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma
    Lin, Huey-Jen
    Liu, Yingguang
    Caroland, Kailey
    Lin, Jiayuh
    CANCERS, 2023, 15 (13)
  • [32] Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma
    Dorst, Daphne N.
    Smeets, Esther M. M.
    Klein, Christian
    Frielink, Cathelijne
    Geijs, Daan
    Trajkovic-Arsic, Marija
    Cheung, Phyllis F. Y.
    Stommel, Martijn W. J.
    Gotthardt, Martin
    Siveke, Jens T.
    Aarntzen, Erik H. J. G.
    van Lith, Sanne A. M.
    MOLECULAR PHARMACEUTICS, 2023, 20 (08) : 4319 - 4330
  • [33] Antigen-presenting cancer-associated fibroblasts are found in immunotherapy-sensitive murine models of pancreatic ductal adenocarcinoma
    Maru, Saumya
    Howe, Kathryn
    Andaloori, Lalitya
    Leatherman, James
    Tandurella, Joseph
    Pearce, Edward J.
    Jaffee, Elizabeth M.
    CANCER RESEARCH, 2024, 84 (02)
  • [34] Patient-specific differences in cancer-associated fibroblasts alter tumor organoid phenotype and chemosensitivity in pancreatic ductal adenocarcinoma
    Jaune-Pons, Emilie
    Klassen, Zachary
    Lu, Rachel
    Shen, Ye
    Hussain, Nadeem
    Sey, Michael
    Leslie, Ken
    Tang, Ephraim
    Skaro, Anton
    Cecchini, Matthew
    Engelage, Crystal
    Porplycia, Danielle
    Welch, Stephen
    Yan, Brian
    Pin, Christopher
    CANCER RESEARCH, 2024, 84 (02)
  • [35] Cancer associated fibroblasts regulate cancer stem cell functions in pancreatic ductal adenocarcinoma
    Begum, Asma
    McMillan, Ross
    Chang, Yu-tai
    Penchev, Vesselin
    Rajeshkumar, N. V.
    Maitra, Anirban
    Goggins, Michael G.
    Eshelman, James R.
    Wolfgang, Christopher
    Rasheed, Zeshaan A.
    Matsui, William H.
    CANCER RESEARCH, 2017, 77
  • [36] Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma
    Xingyi Pan
    Jiaojiao Zhou
    Qian Xiao
    Kenji Fujiwara
    Mengwen Zhang
    Guanglan Mo
    Wei Gong
    Lei Zheng
    Journal of Hematology & Oncology, 14
  • [37] Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma
    Pan, Xingyi
    Zhou, Jiaojiao
    Xiao, Qian
    Fujiwara, Kenji
    Zhang, Mengwen
    Mo, Guanglan
    Gong, Wei
    Zheng, Lei
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [38] Exploring the role of antigen-presenting cancer-associated fibroblasts and CD74 on the pancreatic ductal adenocarcinoma tumor microenvironment
    Michael E. Thomas
    Emily Jie
    Austin M. Kim
    Trenton G. Mayberry
    Braydon C. Cowan
    Harrison D. Luechtefeld
    Mark R. Wakefield
    Yujiang Fang
    Medical Oncology, 42 (1)
  • [39] A comprehensive single cell analysis of cancer-associated fibroblasts (CAFs) reveals subtypes with prognostic impact in pancreatic ductal adenocarcinoma.
    Hussain, Aasia
    Ji, Jiahui
    Srivastava, Prashant K.
    Sadanandam, Anguraj
    CANCER RESEARCH, 2021, 81 (13)
  • [40] An EGFR-activated subset of myofibroblastic cancer-associated fibroblasts supports local metastatic dissemination in pancreatic ductal adenocarcinoma.
    Mucciolo, Gianluca
    Henriquez, Joaquin Araos
    Teles, Sara Pinto
    Manansala, Judhell
    Li, Wenlong
    Lloyd, Eloise G.
    Cheng, Priscilla
    Biffi, Giulia
    CANCER RESEARCH, 2022, 82 (22) : 137 - 138